Nadammal Naresh, Rajput Monika, Gupta Saurabh Kumar, Ivanov Eugene, Reddy Anigani Sudarshan, Suwas Satyam, Chatterjee Kaushik
Department of Materials Engineering, Indian Institute of Science, Bangalore 560012, India.
Tosoh SMD Inc., Grove City, Ohio 43123, United States.
ACS Omega. 2022 Mar 1;7(10):8506-8517. doi: 10.1021/acsomega.1c06261. eCollection 2022 Mar 15.
Laser powder bed fusion (L-PBF) was attempted here to additively manufacture a new generation orthopedic β titanium alloy Ti-35Nb-7Zr-5Ta toward engineering patient-specific implants. Parts were fabricated using four different values of energy density (ED) input ranging from 46.6 to 54.8 J/mm through predefined laser beam parameters from prealloyed powders. All the conditions yielded parts of >98.5% of theoretical density. X-ray microcomputed tomography analyses of the fabricated parts revealed minimal imperfections with enhanced densification at a higher ED input. X-ray diffraction analysis indicated a marginally larger -spacing and tensile residual stress at the highest ED input that is ascribed to the steeper temperature gradients. Cellular to columnar dendritic transformation was observed at the highest ED along with an increase in the size of the solidified features indicating the synergetic effects of the temperature gradient and solidification growth rate. Density measurements indicated ≈99.5% theoretical density achieved for an ED of 50.0 J/mm. The maximum tensile strength of ≈660 MPa was obtained at an ED of 54.8 J/mm through the formation of the columnar dendritic substructure. High ductility ranging from 25 to 30% was observed in all the fabricated parts irrespective of ED. The assessment of cytocompatibility in vitro indicated good attachment and proliferation of osteoblasts on the fabricated samples that were similar to the cell response on commercially pure titanium, confirming the potential of the additively manufactured Ti-35Nb-7Zr-5Ta as a suitable material for biomedical applications. Taken together, these results demonstrate the feasibility of L-PBF of Ti-35Nb-7Zr-5Ta for potentially engineering patient-specific orthopedic implants.
在此尝试采用激光粉末床熔融(L-PBF)技术,通过预合金粉末的预定义激光束参数,以增材制造新一代骨科用β钛合金Ti-35Nb-7Zr-5Ta,用于制造定制化工程植入物。使用四种不同的能量密度(ED)输入值(范围为46.6至54.8 J/mm³)制造零件。所有条件下得到的零件密度均大于理论密度的98.5%。对制造零件的X射线显微计算机断层扫描分析表明,在较高的ED输入下,缺陷极少且致密化程度提高。X射线衍射分析表明,在最高ED输入下,晶格间距略有增大且存在拉伸残余应力,这归因于更陡的温度梯度。在最高ED下观察到胞状到柱状枝晶的转变,同时凝固特征尺寸增大,表明温度梯度和凝固生长速率的协同作用。密度测量表明,对于50.0 J/mm³的ED,可实现约99.5%的理论密度。通过形成柱状枝晶亚结构,在54.8 J/mm³的ED下获得了约660 MPa的最大拉伸强度。无论ED如何,在所有制造零件中均观察到25%至30%的高延展性。体外细胞相容性评估表明,成骨细胞在制造样品上的附着和增殖良好,与在商业纯钛上的细胞反应相似,证实了增材制造的Ti-35Nb-7Zr-5Ta作为生物医学应用合适材料的潜力。综上所述,这些结果证明了Ti-35Nb-7Zr-5Ta的L-PBF技术用于潜在制造定制化骨科植入物的可行性。